Source link : https://www.newshealth.biz/health-news/ensifentrine-may-offer-copd-patients-relief-convenience/
The recent Food and Drug Administration (FDA) approval of ensifentrine marks the first new treatment for patients with persistent chronic obstructive pulmonary disease (COPD) in more than a decade, according to manufacturer Verona Pharma. Ensifentrine offers a new medication and a new delivery method, according to a company press release. Ensifentrine is the first-in-class selective […]
Author : News Health
Publish date : 2024-07-03 09:01:21
Copyright for syndicated content belongs to the linked Source.
Categories